Sign up for free ground shipping on all website orders, no minimum required, and get exclusive coupons!
Maximum quantity allowed is 999
CAS RN: 129938-20-1 | Product Number: D4761
Dapoxetine Hydrochloride

Purity: >98.0%(HPLC)
- (S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenylpropylamine Hydrochloride
- (S)-N,N-Dimethyl-α-[2-(1-naphthyloxy)ethyl]benzylamine Hydrochloride
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
1G |
$55.00
|
1 | 1 | 1 |
|
5G |
$161.00
|
Contact Us | 1 | 36 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | D4761 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__2__3NO·HCl = 341.88 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container ![]() |
1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 129938-20-1 |
Reaxys Registry Number | 10603966 |
PubChem Substance ID | 253660535 |
Merck Index (14) | 2821 |
MDL Number | MFCD08272809 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 97.0 % |
Melting point | 179.0 to 183.0 °C |
Specific rotation [a]20/D | +124 to +129 deg(C=1, MeOH) |
NMR | confirm to structure |
Melting Point | 181 °C |
Specific Rotation | 125° (C=1,MeOH) |
Solubility (soluble in) | Methanol |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. H319 : Causes serious eye irritation. H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
HS Number | 2921.49.4300 |
References
- Dapoxetine hydrochloride (a review)
- Dapoxetine: a novel, fast-acting serotonin reuptake inhibitor (a review)
- Development and validation of a RP-HPLC method for the determination of dapoxetine hydrochloride in pharmaceutical formulation using an experimental design
- Simultaneous estimation and validation of Vardenafil and Dapoxetine Hydrochloride in pharmaceutical formulation by thin layer chromatographic densitometric method
- Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatography
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.